We are live on ! Find out more
DCM

Driehaus Capital Management Portfolio holdings

AUM $13.6B
1-Year Est. Return 173.98%
This Fund
S&P 500
This Quarter Est. Return
+4.28%
1 Year Est. Return
+173.98%
3 Year Est. Return
+706.72%
5 Year Est. Return
+1,585.86%
10 Year Est. Return
+31,592.09%
AUM
$7.69B
AUM Growth
-$228M
Cap. Flow
-$66.9M
Cap. Flow %
-0.87%
Top 10 Hldgs %
18.39%
Holding
467
New
87
Increased
134
Reduced
143
Closed
77

Top Buys

Rank Stock Value
1
CAMT icon
Camtek
CAMT
+$69.7M
2
TDW icon
Tidewater
TDW
+$49.7M
3
ONTO icon
Onto Innovation
ONTO
+$45.1M
4
NE icon
Noble Corp
NE
+$45M
5
SNPS icon
Synopsys
SNPS
+$43.5M

Sector Composition

Rank Sector Weight
1 Technology 23.55%
2 Industrials 20.08%
3 Healthcare 18.28%
4 Consumer Discretionary 9.44%
5 Consumer Staples 7.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CAVA icon
226
CAVA Group
CAVA
$7.51B
$8.79M 0.11%
286,842
+204,443
+248% +$8.92M
KNSA icon
227
Kiniksa Pharmaceuticals
KNSA
$5.73B
$8.75M 0.11%
+503,750
New +$8.49M
PJT icon
228
PJT Partners
PJT
$4.36B
$8.59M 0.11%
+108,082
New +$8.36M
ACI icon
229
Albertsons Companies
ACI
$5.58B
$8.57M 0.11%
376,815
PEN icon
230
Penumbra
PEN
$12.7B
$8.37M 0.11%
34,614
-58,978
-63% -$16.4M
UPWK icon
231
Upwork
UPWK
$1.18B
$8.37M 0.11%
+736,570
New +$9.14M
EMXC icon
232
iShares MSCI Emerging Markets ex China ETF
EMXC
$23.6B
$8.36M 0.11%
167,794
MBLY icon
233
Mobileye
MBLY
$2.04B
$8.26M 0.11%
198,714
-65,658
-25% -$2.53M
TERN
234
DELISTED
Terns Pharmaceuticals
TERN
$8.14M 0.11%
1,617,920
-3,859
-0.2% -$24.5K
CRDO icon
235
Credo Technology Group
CRDO
$40.7B
$8.05M 0.1%
527,697
+195,159
+59% +$3.08M
PSMT icon
236
Pricesmart
PSMT
$6.08B
$7.93M 0.1%
106,541
-19,659
-16% -$1.52M
CPRI icon
237
Capri Holdings
CPRI
$1.88B
$7.91M 0.1%
+150,289
New +$6.82M
RARE icon
238
Ultragenyx Pharmaceutical
RARE
$2.46B
$7.89M 0.1%
221,246
-108,422
-33% -$4.3M
PRCT icon
239
Procept Biorobotics
PRCT
$1.05B
$7.89M 0.1%
240,330
-534
-0.2% -$18.2K
BASE
240
DELISTED
Couchbase
BASE
$7.85M 0.1%
457,386
+194,490
+74% +$3.18M
GENI icon
241
Genius Sports
GENI
$1.89B
$7.84M 0.1%
+1,471,431
New +$9.74M
CACI icon
242
CACI
CACI
$11.3B
$7.65M 0.1%
24,377
+284
+1% +$95K
CCS icon
243
Century Communities
CCS
$1.96B
$7.64M 0.1%
114,418
-90,793
-44% -$6.62M
ESTA icon
244
Establishment Labs
ESTA
$2.73B
$7.53M 0.1%
153,391
-57,661
-27% -$3.45M
TMCI icon
245
Treace Medical Concepts
TMCI
$304M
$7.48M 0.1%
570,582
-906,534
-61% -$16.6M
EG icon
246
Everest Group
EG
$14.4B
$7.25M 0.09%
+19,503
New +$7.08M
RCEL icon
247
Avita Medical
RCEL
$142M
$7.24M 0.09%
+495,768
New +$8.39M
KBR icon
248
KBR
KBR
$4.68B
$7.21M 0.09%
122,353
-62,444
-34% -$3.85M
HEI icon
249
HEICO Corp
HEI
$50.4B
$7.12M 0.09%
43,942
+222
+0.5% +$37.7K
J icon
250
Jacobs Solutions
J
$16.4B
$7.09M 0.09%
+62,817
New +$6.77M

Similar funds

Driehaus Capital Management's Q3 2023 Portfolio in Review

As of Q3 2023, Driehaus Capital Management held 467 positions worth $7.69B, down 2.9% from $7.92B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Driehaus Capital Management's Q3 2023 filing shows 87 new, 134 increased, 143 reduced and 77 closed positions. Its largest new stake was Camtek: 1,412,510 shares worth $87.9M. The largest sale was DICE Therapeutics, Inc. Common Stock, an estimated $94.7M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Industrials and Healthcare.

  • Driehaus Capital Management's largest Q3 2023 buy was Camtek: 1,412,510 shares worth $87.9M.
  • Driehaus Capital Management added most to Structure Therapeutics in Q3 2023, an estimated $40.4M increase.
  • Driehaus Capital Management's biggest Q3 2023 reduction was Inspire Medical Systems, cutting an estimated $49M.
  • Driehaus Capital Management fully exited DICE Therapeutics, Inc. Common Stock in Q3 2023, selling an estimated $94.7M.
  • Driehaus Capital Management's ten largest holdings make up 18% of its $7.69B portfolio in Q3 2023.
  • Driehaus Capital Management opened 87 new positions and closed 77 in Q3 2023.
  • Driehaus Capital Management's portfolio value fell 2.9% quarter-over-quarter to $7.69B.

Based on Driehaus Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.